drugset / Trial / NCT00094627

Adult Primary Insomnia Polysomnographic Study (0928-004)(COMPLETED)

NCT00094627 ↗

Phase 3 Completed 465 enrolled H. Lundbeck A/S
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of the study is to test the safety and effectiveness of the Investigational Drug on insomnia.

Timeline

Start
2004-11
Primary completion
—
Completion
2006-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Gaboxadol Unknown — —

Indications